Matthew W. Foehr - 10 Jun 2021 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
10 Jun 2021
Net transactions value
+$113,800
Form type
4
Filing time
10 Jun 2021, 16:57:28 UTC
Previous filing
01 Jun 2021
Next filing
05 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Purchase $113,800 +20,000 +43% $5.69 66,250 10 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.